Mediwound (MDWD) Scheduled to Post Earnings on Tuesday
Mediwound (NASDAQ:MDWD) is scheduled to post its quarterly earnings results before the market opens on Tuesday, November 13th. Analysts expect Mediwound to post earnings of ($0.19) per share for the quarter.
Shares of NASDAQ MDWD opened at $5.65 on Friday. The company has a market capitalization of $156.61 million, a P/E ratio of -9.11 and a beta of -0.03. Mediwound has a 52 week low of $3.56 and a 52 week high of $7.35.
Several equities research analysts recently commented on the company. Oppenheimer set a $14.00 price target on Mediwound and gave the company a “buy” rating in a research note on Tuesday, August 7th. Wells Fargo & Co set a $11.00 target price on Mediwound and gave the stock a “buy” rating in a report on Tuesday, September 25th. ValuEngine upgraded Mediwound from a “hold” rating to a “buy” rating in a report on Tuesday, October 2nd. Finally, Zacks Investment Research upgraded Mediwound from a “sell” rating to a “hold” rating in a report on Thursday, October 25th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $11.33.
Mediwound Company Profile
MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing novel therapeutics products to address unmet needs. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns in the European Union, Israel, and Argentina.
Recommended Story: Asset Allocation
Receive News & Ratings for Mediwound Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediwound and related companies with MarketBeat.com's FREE daily email newsletter.